Association of mean platelet volume with risk of stroke among 3134 individuals with history of cerebrovascular disease.
D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D001315:Australia / Q000453:epidemiology; D001792:Blood Platelets / Q000166:cytology* / Q000187:drug effects / Q000502:physiology*; D048429:Cell Size / Q000187:drug effects / Q000502:physiology; D002561:Cerebrovascular Disorders / Q000453:epidemiology / Q000503:physiopathology* / Q000517:prevention & control; D002681:China / Q000453:epidemiology; D015897:Comorbidity; D003327:Coronary Disease / Q000453:epidemiology; D004232:Diuretics / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015994:Incidence; D002546:Ischemic Attack, Transient / Q000453:epidemiology / Q000503:physiopathology; D007564:Japan / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D015337:Multicenter Studies as Topic / Q000706:statistics & numerical data; D009520:New Zealand / Q000453:epidemiology; D020913:Perindopril / Q000627:therapeutic use; D011237:Predictive Value of Tests; D016032:Randomized Controlled Trials as Topic / Q000706:statistics & numerical data; D018570:Risk Assessment; D055502:Secondary Prevention; D020521:Stroke / Q000453:epidemiology / Q000503:physiopathology* / Q000517:prevention & control; D013548:Sweden / Q000453:epidemiology
D000806:Angiotensin-Converting Enzyme Inhibitors; D004232:Diuretics; D020913:Perindopril